Tradestie Institutional Equity Comparison Engine

CRMD vs CAPR โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CRMD Overall Edge

CRMD Captures Institutional Edge (2โ€“2 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to CorMedix Inc. (CRMD) driven by superior Valuation, Growth & Margin while CAPR counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, CRMD trades at 49.0x Forward P/E with 41.0% operating margin (-47.7% YoY revenue) versus CAPR at 78.7x Forward P/E and 0.0% operating margin (-7.9% YoY). In options structure, CRMD sits in BREAKDOWN (25th %ile IV; Dealer Gamma Walls on Pro) against CAPR sits in CONSOLIDATION (89th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner CRMD
CRMD 49.0x vs CAPR 78.7x Fwd P/E
Growth & Margin Winner CRMD
Op Margin 41.0% vs 0.0% ยท YoY -47.7% vs -7.9%
Momentum & Technical Winner CAPR
1Y -56.2% vs +44.3% ยท 52W Pos 3% vs 15%
Options & Structure Winner CAPR
BREAKDOWN (25th %ile IV) vs CONSOLIDATION (89th %ile IV)
CRMD NASDAQ
CorMedix Inc.
Pharmaceutical Preparations
$4.92
+5.47% 1D
Market Cap $384.7M
1M Return -32.3%
1Y Return -56.16%
Forward P/E 49.0x
Unified AI Score
53.2 / 100 HOLD
Tech 60.0 Fund 60.0 Flow 69.0 Mom 55.0
CAPR NASDAQ
Capricor Therapeutics Inc
Pharmaceutical Preparations
$8.47
-11.12% 1D
Market Cap $595.4M
1M Return +26.23%
1Y Return +44.29%
Forward P/E 78.7x
Unified AI Score
28.0 / 100 SELL
Tech 50.0 Fund 37.0 Flow 68.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CRMD -56.16% CAPR +44.29% Spread: +102.95 pp (CAPR Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period CRMD Revenue CAPR Revenue CRMD Op. Margin CAPR Op. Margin Margin Edge
FY2018 $0M $0M -6250.4% -917.0% CAPR
FY2019 $0M $0M -7416.3% -769.5% CAPR
FY2020 $0M $0M -11378.4% -4412.6% CAPR
FY2021 $0M $0M -15417.5% -8549.9% CAPR
FY2022 $0M $0M -46819.9% -1163.9% CAPR
FY2023 N/A $30M N/A -95.6% CAPR
FY2024 $40M $20M -51.4% -191.1% CRMD
FY2025 $310M N/A 48.2% N/A CRMD

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CRMD (7) vs CAPR (3)
Institutional Metric CRMD CAPR Criterion Row Winner
Market Capitalization Scale $384.7M $595.4M Larger Scale CAPR
Trailing P/E Ratio Valuation 2.4x 78.7x Lower Multiple CRMD
Forward P/E Ratio Valuation 49.0x 78.7x Lower Multiple CRMD
Revenue Growth (YoY) Growth -47.7% -7.9% Higher Growth CAPR
Operating Margin (TTM) Profitability 41.0% 0.0% Higher Margin CRMD
Net Profit Margin Profitability 15.5% 0.0% Higher Margin CRMD
Return on Equity (ROE) Capital Efficiency 15.3% -100.5% Higher ROE CRMD
52-Week Range Position Momentum 3% ($5โ€“$13) 15% ($3โ€“$40) Stronger Trend CAPR
Beta / 30D Volatility Risk Regime 1.20ฮฒ ยท 107% Vol 1.52ฮฒ ยท 152% Vol Lower Realized Risk CRMD
Unified Institutional Score Composite Signal 53.2 / 100 (HOLD) 28.0 / 100 (SELL) Higher Composite CRMD

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CRMD vs CAPR Buy Guide
CRMD BREAKDOWN
109d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 25th %ile
IV Regime Compressed (<25th %ile)
Live CRMD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CAPR CONSOLIDATION
56d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 89th %ile
IV Regime Extreme (>80th %ile)
Live CAPR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CRMD nor CAPR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.